Precision Biologics to Deliver two Poster Presentations on our Clinical and Scientific Programs at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting at the Walter E Washington Convention Center, Washington DC Nov 12-13, 2021

November 12th: poster number 883 (12:40–2:10 p.m. and 7–8:30 p.m.)
Title: An anti-carcinoma monoclonal antibody (mAb) NEO-201 can also target human acute myeloid leukemia (AML) cell lines in vitro.

November 13th: poster number 840 (12:30–2:00 p.m. and 7–8:30 p.m.)
Title: A therapeutic humanized anti-carcinoma monoclonal antibody (mAb) can also identify immunosuppressive regulatory T (Tregs) cells and down regulate Treg-mediated immunosuppression